Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Determining rates of hepatitis C in a clozapine treated cohort.

Sockalingam S, Shammi C, Powell V, Barker L, Remington G.

Schizophr Res. 2010 Dec;124(1-3):86-90. doi: 10.1016/j.schres.2010.06.005.

PMID:
20605572
2.

Hepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohort.

Freudenreich O, Gandhi RT, Walsh JP, Henderson DC, Goff DC.

Psychosomatics. 2007 Sep-Oct;48(5):405-11.

PMID:
17878499
3.

Epidemiological survey of hepatitis C virus infection in a cohort of patients from a ser.T in naples, Italy.

Curcio F, Villano G, Masucci S, Plenzik M, Veneruso C, De Rosa G.

J Addict Med. 2011 Mar;5(1):43-9. doi: 10.1097/ADM.0b013e3181d131e0.

PMID:
21769046
4.

Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?

Schmidt AJ, Falcato L, Zahno B, Burri A, Regenass S, Müllhaupt B, Bruggmann P.

BMC Public Health. 2014 Jan 6;14:3. doi: 10.1186/1471-2458-14-3.

5.

Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.

Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J.

Arch Virol. 2013 Sep;158(9):1889-94. doi: 10.1007/s00705-013-1681-z.

PMID:
23553454
6.

Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy.

Quaglio GL, Lugoboni F, Pajusco B, Sarti M, Talamini G, Mezzelani P, Des Jarlais DC; GICS..

J Viral Hepat. 2003 Sep;10(5):394-400.

PMID:
12969192
7.

Hepatitis B and C in New South Wales prisons: prevalence and risk factors.

Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW.

Med J Aust. 1997 Feb 3;166(3):127-30.

PMID:
9059433
8.

Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases.

Mohamed HI, Saad ZM, Abd-Elreheem EM, Abd-ElGhany WM, Mohamed MS, Abd Elnaeem EA, Seedhom AE.

J Infect Public Health. 2013 Jun;6(3):186-95. doi: 10.1016/j.jiph.2012.12.003.

PMID:
23668463
9.

Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.

Lucas GM, Jing Y, Sulkowski M, Abraham AG, Estrella MM, Atta MG, Fine DM, Klein MB, Silverberg MJ, Gill MJ, Moore RD, Gebo KA, Sterling TR, Butt AA; NA-ACCORD of the IeDEA..

J Infect Dis. 2013 Oct 15;208(8):1240-9. doi: 10.1093/infdis/jit373.

10.

Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.

Tyson GL, Kramer JR, Duan Z, Davila JA, Richardson PA, El-Serag HB.

Hepatology. 2013 Aug;58(2):538-45. doi: 10.1002/hep.26400.

11.

Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.

Shores NJ, Maida I, Soriano V, Núnez M.

J Hepatol. 2008 Sep;49(3):323-8. doi: 10.1016/j.jhep.2008.04.010.

PMID:
18486266
12.

The natural history of hepatitis C virus infection: host, viral, and environmental factors.

Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D.

JAMA. 2000 Jul 26;284(4):450-6.

PMID:
10904508
14.

Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.

Mortimer AM, Singh P, Shepherd CJ, Puthiryackal J.

Clin Schizophr Relat Psychoses. 2010 Apr;4(1):49-55. doi: 10.3371/CSRP.4.1.4.

PMID:
20643629
15.

Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.

Santana Rodríguez OE, Malé Gil ML, HernándezSantana JF, Limiñana Cañal JM, Martín Sánchez AM.

Eur J Epidemiol. 1998 Sep;14(6):555-61.

PMID:
9794122
16.

Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.

Lamberti JS, Costea GO, Olson D, Crilly JF, Maharaj K, Tu X, Groman A, Dietz MB, Bushey MP, Olivares T, Wiener K.

J Clin Psychiatry. 2005 Jul;66(7):900-6.

PMID:
16013906
17.

Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.

Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart ML, Strathdee SA, Currie SL, Schechter MT, O'Shaughnessy MV.

CMAJ. 2001 Oct 2;165(7):889-95.

18.

Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.

Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.

Trop Gastroenterol. 2007 Jan-Mar;28(1):19-23.

PMID:
17896605
19.

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.

Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, DiBisceglie A, Hoofnagle J, Shih JW, et al.

N Engl J Med. 1996 Jun 27;334(26):1691-6.

20.

Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.

Dong Y, Qiu C, Xia X, Wang J, Zhang H, Zhang X, Xu J.

Arch Virol. 2015 Apr;160(4):929-36. doi: 10.1007/s00705-014-2311-0.

PMID:
25616842
Items per page

Supplemental Content

Support Center